Andrew S Azman

InstitutionMédecins Sans Frontières
AddressGeneva
Switzerland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 22 Covid-19 publications, with a maximum of 3 publications in June 2021
    All Publications
    Bar chart showing 86 publications over 11 distinct years, with a maximum of 16 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chen X, Chen Z, Azman AS, Sun R, Lu W, Zheng N, Zhou J, Wu Q, Deng X, Zhao Z, Chen X, Ge S, Yang J, Leung DT, Yu H. Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis. Clin Infect Dis. 2021 Jul 24. PMID: 34302458.
      Citations: 14     Fields:    
    2. Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12. PMID: 34245905.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    3. Bi Q, Lessler J, Eckerle I, Lauer SA, Kaiser L, Vuilleumier N, Cummings DAT, Flahault A, Petrovic D, Guessous I, Stringhini S, Azman AS. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643. PMID: 34131124.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    4. Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS, Guessous I. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455. PMID: 34103517.
      Citations: 2     Fields:    Translation:Humans
    5. Wiens KE, Mawien PN, Rumunu J, Slater D, Jones FK, Moheed S, Caflisch A, Bior BK, Jacob IA, Lako RL, Guyo AG, Olu OO, Maleghemi S, Baguma A, Hassen JJ, Baya SK, Deng L, Lessler J, Demby MN, Sanchez V, Mills R, Fraser C, Charles RC, Harris JB, Azman AS, Wamala JF. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201. Emerg Infect Dis. 2021 06; 27(6):1598-1606. PMID: 34013872.
      Citations: 4     Fields:    Translation:Humans
    6. Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021 May 27. PMID: 34043763.
      Citations: 12     Fields:    
    7. Lessler J, Grabowski MK, Grantz KH, Badillo-Goicoechea E, Metcalf CJE, Lupton-Smith C, Azman AS, Stuart EA. Household COVID-19 risk and in-person schooling. Science. 2021 06 04; 372(6546):1092-1097. PMID: 33927057.
      Citations: 30     Fields:    Translation:HumansPHPublic Health
    8. Chen X, Chen Z, Azman AS, Deng X, Sun R, Zhao Z, Zheng N, Chen X, Lu W, Zhuang T, Yang J, Viboud C, Ajelli M, Leung DT, Yu H. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021 05; 9(5):e598-e609. PMID: 33705690.
      Citations: 49     Fields:    Translation:Humans
    9. Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, de Mestral C, Picazio A, Pennacchio F, Wisniak A, Richard A, Baysson H, Loizeau A, Balavoine JF, Trono D, Pittet D, Posfay-Barbe K, Flahault A, Chappuis F, Kherad O, Vuilleumier N, Kaiser L, Azman AS, Guessous I. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021 05; 21(5):600-601. PMID: 33539733.
      Citations: 12     Fields:    Translation:Humans
    10. De Ridder D, Sandoval J, Vuilleumier N, Azman AS, Stringhini S, Kaiser L, Joost S, Guessous I. Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters. Front Public Health. 2020; 8:626090. PMID: 33614571.
      Citations: 7     Translation:Humans
    11. Zhang Z, Bi Q, Fang S, Wei L, Wang X, He J, Wu Y, Liu X, Gao W, Zhang R, Gong W, Su Q, Azman AS, Lessler J, Zou X. Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study. Lancet Microbe. 2021 Feb; 2(2):e79-e87. PMID: 33495759.
      Citations: 16     
    12. O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021 02; 590(7844):140-145. PMID: 33137809.
      Citations: 174     Fields:    Translation:HumansPHPublic Health
    13. Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, Mills R, Teng E, Kamruzzaman M, Garcia-Beltran WF, Astudillo M, Yang D, Miller TE, Oliver E, Fischinger S, Atyeo C, Iafrate AJ, Calderwood SB, Lauer SA, Yu J, Li Z, Feldman J, Hauser BM, Caradonna TM, Branda JA, Turbett SE, LaRocque RC, Mellon G, Barouch DH, Schmidt AG, Azman AS, Alter G, Ryan ET, Harris JB, Charles RC. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020 10 08; 5(52). PMID: 33033172.
      Citations: 183     Fields:    Translation:HumansCellsPHPublic Health
    14. Zheng Q, Jones FK, Leavitt SV, Ung L, Labrique AB, Peters DH, Lee EC, Azman AS. HIT-COVID, a global database tracking public health interventions to COVID-19. Sci Data. 2020 08 27; 7(1):286. PMID: 32855428.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    15. Perez-Saez J, Lauer SA, Kaiser L, Regard S, Delaporte E, Guessous I, Stringhini S, Azman AS. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2021 04; 21(4):e69-e70. PMID: 32679085.
      Citations: 57     Fields:    Translation:HumansPHPublic Health
    16. Truelove S, Abrahim O, Altare C, Lauer SA, Grantz KH, Azman AS, Spiegel P. The potential impact of COVID-19 in refugee camps in Bangladesh and beyond:  A modeling study. PLoS Med. 2020 06; 17(6):e1003144. PMID: 32544156.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    17. Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319. PMID: 32534626.
      Citations: 337     Fields:    Translation:HumansCellsPHPublic Health
    18. Bryant JE, Azman AS, Ferrari MJ, Ferrari MJ, Arnold BF, Boni MF, Boum Y, Hayford K, Luquero FJ, Mina MJ, Rodriguez-Barraquer I, Wu JT, Wade D, Vernet G, Leung DT. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward. Sci Immunol. 2020 05 19; 5(47). PMID: 32430309.
      Citations: 62     Fields:    Translation:HumansCellsPHPublic Health
    19. Lemaitre JC, Perez-Saez J, Azman AS, Rinaldo A, Fellay J. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland. Swiss Med Wkly. 2020 05 18; 150:w20295. PMID: 32472939.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    20. Azman AS, Luquero FJ. From China: hope and lessons for COVID-19 control. Lancet Infect Dis. 2020 07; 20(7):756-757. PMID: 32251637.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    21. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 05; 172(9):577-582. PMID: 32150748.
      Citations: 1710     Fields:    Translation:HumansCellsPHPublic Health
    Azman's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (170)
    Explore
    _
    Co-Authors (186)
    Explore
    _
    Similar People (60)
    Explore
    _